Skip to main content

Advertisement

Table 1 Demographic data at study entry for the Safety population of 32 postmenopausal Caucasian women with untreated primary breast cancer

From: Neoadjuvant letrozole in postmenopausal estrogen and/or progesterone receptor positive breast cancer: A phase IIb/III trial to investigate optimal duration of preoperative endocrine therapy

  Mean ± SD Median (Range)
Age (yrs) 68.4 ± 7.2 67.0 (56–85)
Weight (kg) 72.6 ± 16.4 68.5 (49–120)
BMI (kg/m2) 27.2 ± 5.4 26.0 (20.1–44.6)